ProPhase Labs Inc (PRPH)
0.6105
-0.04
(-6.52%)
USD |
NASDAQ |
Dec 20, 16:00
0.6105
0.00 (0.00%)
After-Hours: 20:00
ProPhase Labs Shareholders Equity (Quarterly): 38.13M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Fonar Corp | 168.69M |
| XWELL Inc | 6.304M |
| Applied DNA Sciences Inc | 9.143M |
| Veracyte Inc | 1.176B |
| OncoCyte Corp | 9.711M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 91.81M |
| Total Liabilities (Quarterly) | 53.68M |
| Debt to Equity Ratio | 0.4506 |
| Current Ratio | 1.472 |
| Net Debt Paydown Yield | -3.26% |